Veradermics, Inc (MANE) › Cash & EquivalentsVeradermics, Inc (MANE) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $53.08M2025: $21.77M$21.77M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$21.77M-59.0%2024$53.08M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share